Broadly Neutralizing Antibodies and the Development of Vaccines

JAMA. 2015 Jun;313(24):2419-20. doi: 10.1001/jama.2015.2427.

Authors

Barton F Haynes¹, Todd Bradley²

Affiliations

¹ Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina2Department of Medicine, Duke University School of Medicine, Durham, North Carolina3Department of Immunology, Duke University School of Medicine, Durham, North Carolin.
² Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina3Department of Immunology, Duke University School of Medicine, Durham, North Carolina.

PMID: 26103022
DOI: 10.1001/jama.2015.2427

No abstract available

MeSH terms

AIDS Vaccines / immunology*
Animals
Antibodies, Neutralizing / immunology
Antibodies, Neutralizing / therapeutic use*
B-Lymphocytes / immunology*
HIV Antibodies
HIV Infections / immunology
HIV Infections / prevention & control*
Humans
Vaccines / immunology

Substances

AIDS Vaccines
Antibodies, Neutralizing
HIV Antibodies
Vaccines

Grants and funding

UM1 AI100645/AI/NIAID NIH HHS/United States